| Financial Year |
March 31 2023 |
| Monetary Funds |
2,567,257,537.86 |
| Held-for-trading Financial Assets |
2,000,000.00 |
| Notes Receivable |
76,568,725.80 |
| Accounts Receivable |
5,950,012,887.69 |
| Advances to Suppliers |
303,631,674.47 |
| Other Receivables |
744,502,437.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,168,865,001.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
362,046,493.16 |
| Other Current Assets |
144,109,601.83 |
| Total Current Assets |
13,648,358,506.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
210,600,218.50 |
| Long-term Equity Investment |
262,899,284.99 |
| Investment Properties |
-- |
| Fixed Assetes |
6,012,287,666.73 |
| Under-construction Projects |
334,557,167.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
855,936,188.90 |
| R&D expenses |
62,251,839.68 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
43,639,340.64 |
| Deferred Income Tax Assets |
360,004,293.45 |
| Other Non-Current Assets |
26,999,271.67 |
| Sub-Total of Non-Current Assets |
8,218,867,930.58 |
| Total Assets |
21,867,226,436.84 |
| Short-Term Loans |
839,223,219.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,827,656,523.96 |
| Accounts Payable |
2,456,394,828.91 |
| Accounts Received In Advance |
34,604,795.59 |
| Employee Compensation Payable |
82,185,778.22 |
| Taxes Payable |
86,107,186.11 |
| Interest Payable |
-- |
| Dividend Payable |
8,290,994.13 |
| Other payables |
397,568,618.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,613,015,056.23 |
| Other Current Liabilities |
52,046,907.85 |
| Sub-Total of Current Liabilities |
8,934,026,954.25 |
| Long-term Loans |
6,919,431,738.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
124,453,751.57 |
| Special Payable |
-- |
| Estimatied Liabilities |
224,735,076.34 |
| Deferred Income Tax Liabilities |
403,565,919.27 |
| Other Non-Current Liabilities |
353,597,991.23 |
| Sub-Total of Non-Current Liabilities |
8,171,923,951.21 |
| Total Liabilities |
17,105,950,905.46 |
| Paid-In Capital(Or Share Stock) |
1,087,212,465.00 |
| Capital Surplus |
2,365,301,953.10 |
| Surplus Reserve |
260,099,443.11 |
| LESS:Treasury Stock |
99,922,347.37 |
| Undistributed Profits |
847,786,652.99 |
| Minority Stockholder's Interest |
193,615,926.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,567,659,604.39 |
| Owner's Equity（Stockholder's Equity） |
4,761,275,531.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,867,226,436.84 |
